Woman and Man | 60 years and more
- | Country :
- France
- | organs :
- Leucémies aiguës
- | Specialty :
- Chimiothérapie
- Gériatrie
Extract
A phase I, open-label, multi-centre, multiple ascending dose study to assess the safety and tolerability of AZD1152 in combination with low dose cytosine arabinoside (LDAC) in patients with acute myeloid leukaemia (AML).
Scientific Abstract
en cours d'intégration;